⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22667381 | 0.87 | MTNR1A (0.41) | — | |
| SCHEMBL23837376 | 0.86 | SMYD3 (0.34) | — | |
| SCHEMBL18797980 | 0.85 | NAMPT (0.35) | — | |
| SCHEMBL19663642 | 0.84 | MAPT (0.34) | — | |
| SCHEMBL17337236 | 0.84 | PARP1 (0.32) | — | |
| SCHEMBL17337233 | 0.84 | PARP1 (0.32) | — | |
| SCHEMBL18797961 | 0.84 | — | — | |
| SCHEMBL19663651 | 0.84 | MTNR1A (0.32) | — | |
| SCHEMBL23130007 | 0.82 | AAK1 (0.32) | — | |
| SCHEMBL19228009 | 0.82 | DRD2 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9783555-B2 | Beta-lactamase inhibitors | VenatoRx Pharmaceuticals, Inc. (US) | 2017-10-10 | — | — | US | disclosed |
| US-20170226135-A1 | BETA-LACTAMASE INHIBITORS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2017-08-10 | — | — | US | disclosed |